Form 4: Director Susan Knight Increases Stake in Anteris (AVR)

Director Susan Elizabeth Knight acquired 11,000 shares of Anteris Technologies Global Corp. common stock at a weighted average price of $9.2935.

Summary

• Director Susan Elizabeth Knight purchased 11,000 shares of Anteris Technologies Global Corp. (AVR) common stock.
• The transaction occurred on June 2, 2026.
• The shares were acquired at a weighted average price of $9.2935 per share.
• The purchase consisted of 5,000 shares at $9.31 and 6,000 shares at $9.2797.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level buying typically indicates internal confidence in the company's current trajectory.

Positives

• Director demonstrates confidence in the company's future by increasing personal equity stake.
• The purchase was made via open market acquisition.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable for this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal by the market, reflecting management's alignment with shareholder interests and confidence in the company's long-term valuation.

Comparison to Industry Standards

• Insider purchases by board members are standard corporate governance signals in the biotechnology and medical device sectors.
• The volume of shares purchased is consistent with typical director-level equity accumulation.

Stakeholder Impact

• Shareholders may view this as a vote of confidence from leadership.

Key Dates

Keywords

Anteris Technologies, AVR, Insider Trading, Director Purchase, SEC Form 4